- Home
- EDSA vs RIME Comparison
EDSA vs RIME Comparison
Compare EDSA & RIME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- RIME
- Stock Information
- Founded
- EDSA 2015
- RIME 1982
- Country
- EDSA Canada
- RIME United States
- Employees
- EDSA N/A
- RIME N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- RIME
- Sector
- EDSA Health Care
- RIME
- Exchange
- EDSA Nasdaq
- RIME NYSE
- Market Cap
- EDSA 6.1M
- RIME 4.9M
- IPO Year
- EDSA N/A
- RIME 1994
- Fundamental
- Price
- EDSA $1.89
- RIME $0.09
- Analyst Decision
- EDSA Strong Buy
- RIME
- Analyst Count
- EDSA 1
- RIME 0
- Target Price
- EDSA $21.00
- RIME N/A
- AVG Volume (30 Days)
- EDSA 31.2K
- RIME 84.2M
- Earning Date
- EDSA 02-07-2025
- RIME 11-19-2024
- Dividend Yield
- EDSA N/A
- RIME N/A
- EPS Growth
- EDSA N/A
- RIME N/A
- EPS
- EDSA N/A
- RIME N/A
- Revenue
- EDSA N/A
- RIME $32,479,657.00
- Revenue This Year
- EDSA N/A
- RIME N/A
- Revenue Next Year
- EDSA N/A
- RIME N/A
- P/E Ratio
- EDSA N/A
- RIME N/A
- Revenue Growth
- EDSA N/A
- RIME 11.81
- 52 Week Low
- EDSA $1.69
- RIME $0.07
- 52 Week High
- EDSA $5.99
- RIME $1.97
- Technical
- Relative Strength Index (RSI)
- EDSA 37.11
- RIME N/A
- Support Level
- EDSA $1.73
- RIME N/A
- Resistance Level
- EDSA $2.55
- RIME N/A
- Average True Range (ATR)
- EDSA 0.18
- RIME 0.00
- MACD
- EDSA 0.03
- RIME 0.00
- Stochastic Oscillator
- EDSA 25.58
- RIME 0.00
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About RIME ALGORHYTHM HOLDINGS INC
Algorhythm Holdings Inc is a holding company with two primary investments. It operates through its subsidiaries, one of which is an emerging leader in the AI-enabled global logistics industry. The other subsidiary is engaged in consumer karaoke products, Which designs and distributes the industry's widest assortment of at-home and in-car karaoke entertainment products.